To describe the correlation of clinical features with the methylation level of the selected MAL2 CpG sites in glioma, the average of the methylation levels of MAL2 cg1–cg9 was used to represent the MAL2 methylation degree. The gene discussed is MAL2; the disease is central nervous system cancer.